Tmunity Therapeutics
AcquiredPhiladelphia, US · Founded 2015 · Delaware corporation · 7 known investors
Find your way into Tmunity Therapeutics
Sign up to see every warm intro you have to Tmunity Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tmunity Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Kite Pharma (Gilead Sciences) December 2022 · terms undisclosed — Undisclosed · source ↗
Tmunity Therapeutics was a University of Pennsylvania spinout developing engineered T-cell therapies, including CAR-T and TCR-based treatments, for cancers.
Founders & leadership
Tmunity Therapeutics was founded in 2015 by Anne Chew.
Board
Investors · 7
How we know: a16z's portfolio · funding news · press coverage · Not right? Tell us
How we know: Khosla Ventures's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$175M disclosed across 5 rounds · 2015–2019
▶$75MraisedOct 2019 · 7 investors · BiotechnologyRule 506(b)
- PATRICK GRAYDirector
- GARRY NICHOLSONDirector
- USMAN AZAMExecutive Officer, Director
- YAN ZHANGDirector
- JASON KRENTZExecutive Officer
- MOJI JAMESExecutive Officer
- CHRISTINA COUGHLINExecutive Officer
- GRAEME BELLExecutive Officer
- JUDITH LIDirector
- MICHAEL CHRISTIANOExecutive Officer
- BETH SEIDENBERGDirector
- SEAN PARKERDirector
- Offering amount
- $75M
- Amount sold
- $75M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$85MraisedMay 2018 · 5 investors · BiotechnologyRule 506(b)
- JUDITH LIDirector
- MICHAEL CHRISTIANOExecutive Officer
- USMAN AZAMExecutive Officer
- JIANG ZHANGDirector
- SEAN PARKERDirector
- KEVIN MAHONEYDirector
- ALESSANDRO RIVADirector
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$5MraisedJan 2018 · 1 investors · BiotechnologyRule 506(b)
- MICHAEL CHRISTIANOExecutive Officer
- USMAN AZAMExecutive Officer
- KEVIN MAHONEYDirector
- ANNE CHEWDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$5MraisedFeb 2016 · 2 investors · PharmaceuticalsRule 506(b)
- Kevin MahoneyDirector
- Anne ChewExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$5MraisedDec 2015 · 1 investors · PharmaceuticalsRule 506(b)
- Anne ChewExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Tmunity Therapeutics do?
- Tmunity Therapeutics was a University of Pennsylvania spinout developing engineered T-cell therapies, including CAR-T and TCR-based treatments, for cancers.
- Who founded Tmunity Therapeutics?
- Tmunity Therapeutics was founded by Anne Chew in 2015.
- Who are Tmunity Therapeutics's investors?
- Tmunity Therapeutics's investors include Andreessen Horowitz, Khosla Ventures, Kleiner Perkins, LAV, Lilly Asia Ventures, Militia Hill Ventures, Gilead Sciences.
- How much funding has Tmunity Therapeutics raised?
- Tmunity Therapeutics has disclosed $175M raised across 5 rounds.
- Where is Tmunity Therapeutics headquartered?
- Tmunity Therapeutics is headquartered in Philadelphia, US.

